MEPs Approve EMA Move To Amsterdam, But Insist Deadlines Must Be Met
Executive Summary
An EU parliamentary committee has OKd the EMA’s move to Amsterdam, but with caveats. MEPs are unhappy with the way the agency’s new home was decided and have called for changes to the procedure used to choose EU agency locations in future.
You may also be interested in...
Brexit Won’t Delay Drug Approvals, EMA’s Rasi Reassures Industry
The EU’s centralized drug approval process will not be disrupted regardless of the number of employees the European Medicines Agency might lose when it relocates from London to Amsterdam, Guido Rasi pledged yesterday at the DIA Europe 2018 conference.
EMA Queries Cost Of New Dutch HQ As Milan Steps Up Legal Fight
The Dutch government has insisted that the relocation of the European Medicines Agency to Amsterdam will go smoothly and that the agency’s permanent headquarters will be ready on time, despite an argument over the costs of the new premises and a renewed drive by Italy to have the EMA located in Milan.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.